Intellia Therapeutics, Inc. (NTLA)

Last Three Months

20-Jan-24 -- 19-Apr-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

24

0

7

+1

0

+2

0

+3

Two Year Chart

20-Apr-22 -- 19-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
05-Mar-24 4:10 PM View:	01-Mar-24 Grant 0	Leonard John M. President and CEO Director		Intellia Therapeutics, Inc. - NTLA	13% 904.9K to 1.02M	0	0	--	--	Show Txns Hide Txns

05-Mar-24 4:10 PM View:	01-Mar-24 Grant 0	Goddard Glenn EVP, Chief Financial Officer		Intellia Therapeutics, Inc. - NTLA	71% 40.59K to 69.21K	0	0	--	--	Show Txns Hide Txns

05-Mar-24 4:10 PM View:	01-Mar-24 Grant 0	Sepp-Lorenzino Laura EVP, Chief Scientific Officer		Intellia Therapeutics, Inc. - NTLA	86% 43.93K to 81.89K	0	0	--	--	Show Txns Hide Txns

05-Mar-24 4:10 PM View:	01-Mar-24 Grant 0	Lebwohl David EVP, Chief Medical Officer		Intellia Therapeutics, Inc. - NTLA	71% 54.37K to 93.07K	0	0	--	--	Show Txns Hide Txns

05-Mar-24 4:10 PM View:	04-Mar-24 Sale ($75.78K)	Basta James EVP, General Counsel		Intellia Therapeutics, Inc. - NTLA	58% 51.47K to 81.57K	0	0	--	--	Show Txns Hide Txns

05-Mar-24 4:10 PM View:	01-Mar-24 Grant 0	Hicks Derek EVP, Chief Business Officer		Intellia Therapeutics, Inc. - NTLA	79% 36.99K to 66.38K	0	0	--	--	Show Txns Hide Txns

05-Mar-24 4:10 PM View:	04-Mar-24 Sale ($19.96K)	Clark Eliana EVP, Chief Technical Officer		Intellia Therapeutics, Inc. - NTLA	75% 40.84K to 71.47K	0	0	--	--	Show Txns Hide Txns